DRUG: Dasabuvir, ombitasvir, paritaprevir and ritonavir
Help
Entry
D10582 Mixture Drug
Name
Dasabuvir, ombitasvir, paritaprevir and ritonavir;
Viekira pak (TN)
Product
VIEKIRA PAK (AbbVie)
Component
(Dasabuvir sodium hydrate [DR:
D10581
] | Dasabuvir [DR:
D10553
]), (Ombitasvir hydrate [DR:
D10598
] | Ombitasvir [DR:
D10576
]), (Paritaprevir hydrate [DR:
D10597
] | Paritaprevir [DR:
D10580
]), Ritonavir [DR:
D00427
]
Remark
ATC code:
J05AP52
Product:
D10582<US>
Efficacy
Antiviral
Disease
Chronic hepatitis C virus infection [DS:
H00413
]
Interaction
DDI search
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:
br08303
]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP Antivirals for treatment of HCV infections
J05AP52 Dasabuvir, ombitasvir, paritaprevir and ritonavir
D10582 Dasabuvir, ombitasvir, paritaprevir and ritonavir <US>
USP drug classification [BR:
br08302
]
Antivirals
Anti-hepatitis C (HCV) Agents
Dasabuvir/ Ombitasvir/ Paritaprevir/ Ritonavir
D10582 Dasabuvir, ombitasvir, paritaprevir and ritonavir
New drug approvals in the USA [
br08319.html
]
New molecular entities and new therapeutic biological products
D10582
New drug approvals in the USA, Europe and Japan [
br08328.html
]
Approval dates by FDA, EMA and PMDA
D10582
Pharmacogenomic biomarkers [
br08341.html
]
Polymorphisms and mutations affecting drug response
D10582
BRITE hierarchy
Other DBs
PubChem:
254741544
ChEBI:
85177
LinkDB
All DBs
» Japanese version
» Back
DBGET
integrated database retrieval system
